CGP-59326
Code | Size | Price |
---|
TAR-T30849-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T30849-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T30849-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
CGP-59326 is an epidermal growth factor receptor (EGFR) antagonist, which is used in anti-cancer research.
CAS:
173458-56-5
Formula:
C14H13ClN4
Molecular Weight:
272.74
Purity:
0.98
SMILES:
Cc1[nH]c2ncnc(Nc3cccc(Cl)c3)c2c1C
References
1. T?rring N, Dagnaes-Hansen F, S?rensen BS, Nex? E, Hynes NE. ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002. Prostate. 2003 Jul 1;56(2):142-9. PubMed PMID: 12746839.
2. Motoyama AB, Hynes NE, Lane HA. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides. Cancer Res. 2002 Jun 1;62(11):3151-8. PubMed PMID: 12036928.